Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Filomia

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Medicine|September 24, 2016
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomographyRoberto Filomia, Sergio Maimone, Gaia Caccamo, et al.
Antiviral Therapy|April 4, 2020
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohortMaria Giovanna Quaranta, Stefano Rosato, Luigina Ferrigno, et al.
The American Journal of Gastroenterology|August 16, 2022
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varicesVincenza Calvaruso, Ciro Celsa, Roberta D'Ambrosio, et al.
Hepatology International|April 13, 2020
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Monica Monti, et al.
Journal of Hepatology|April 4, 2020
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosisAngelo Sangiovanni, Eleonora Alimenti, Riccardo Gattai, et al.
Plos One|March 1, 2017
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort StudyLoreta A Kondili, Giovanni Battista Gaeta, Donatella Ieluzzi, et al.
Plos One|January 3, 2018
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort StudyLoreta A Kondili, Giovanni Battista Gaeta, Donatella Ieluzzi, et al.
Hepatology (Baltimore, Md.)|December 17, 2021
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohortLoreta A Kondili, Monica Monti, Maria Giovanna Quaranta, et al.
Plos One|October 5, 2017
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER networkLoreta A Kondili, Giovanni Battista Gaeta, Maurizia Rossana Brunetto, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Medicine|September 24, 2016
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomographyRoberto Filomia, Sergio Maimone, Gaia Caccamo, et al.
Antiviral Therapy|April 4, 2020
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohortMaria Giovanna Quaranta, Stefano Rosato, Luigina Ferrigno, et al.
The American Journal of Gastroenterology|August 16, 2022
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varicesVincenza Calvaruso, Ciro Celsa, Roberta D'Ambrosio, et al.
Hepatology International|April 13, 2020
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Monica Monti, et al.
Journal of Hepatology|April 4, 2020
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosisAngelo Sangiovanni, Eleonora Alimenti, Riccardo Gattai, et al.
Plos One|March 1, 2017
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort StudyLoreta A Kondili, Giovanni Battista Gaeta, Donatella Ieluzzi, et al.
Plos One|January 3, 2018
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort StudyLoreta A Kondili, Giovanni Battista Gaeta, Donatella Ieluzzi, et al.
Hepatology (Baltimore, Md.)|December 17, 2021
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohortLoreta A Kondili, Monica Monti, Maria Giovanna Quaranta, et al.
Plos One|October 5, 2017
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER networkLoreta A Kondili, Giovanni Battista Gaeta, Maurizia Rossana Brunetto, et al.
Pageof 3